e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Systemic and airway biomarkers in respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Activin –A and follistatin in sputum supernatant and BAL in patients with asthma
A. Papaporfyriou, P. Bakakos, K. Kostikas, G. Papatheodorou, G. Hillas, E. Konstantelou, N. Koulouris, S. Papiris, S. Loukides (Athens, Greece)
Source:
Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Session:
Systemic and airway biomarkers in respiratory diseases
Session type:
Thematic Poster Session
Number:
832
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Papaporfyriou, P. Bakakos, K. Kostikas, G. Papatheodorou, G. Hillas, E. Konstantelou, N. Koulouris, S. Papiris, S. Loukides (Athens, Greece). Activin –A and follistatin in sputum supernatant and BAL in patients with asthma. Eur Respir J 2013; 42: Suppl. 57, 832
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Periostin in lower airway samples and serum, a novel asthma marker?
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016
Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Serum periostin but not airway
POSTN
expression is reduced in smokers with asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Assessment of ATP degradation in bronchoalveolar lavage fluid
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept